Enables very-low-density lipoprotein particle receptor activity. Acts upstream of or within triglyceride metabolic process. Predicted to be located in plasma membrane. Predicted to be part of chylomicron; low-density lipoprotein particle; and very-low-density lipoprotein particle. Orthologous to human APOBR (apolipoprotein B receptor). [provided by Alliance of Genome Resources, Apr 2022]